Trial Profile
Pharmacokinetics of the LY2605541 in subjects with varying degrees of renal function
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 30 Jan 2018
Price :
$35
*
At a glance
- Drugs Insulin peglispro (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Pharmacokinetics
- 30 Jan 2018 New trial record